Biopharmaceutical study of the hepato-biliary transport of drugs. VII. Improvement of the bioavailability of rifampicin by dosage form design

Chem Pharm Bull (Tokyo). 1978 Jan;26(1):19-24. doi: 10.1248/cpb.26.19.
No abstract available

MeSH terms

  • Animals
  • Bile / metabolism*
  • Biological Availability
  • Dogs
  • Dosage Forms
  • Lipids
  • Pharmaceutical Vehicles
  • Rats
  • Rifampin / metabolism*

Substances

  • Dosage Forms
  • Lipids
  • Pharmaceutical Vehicles
  • Rifampin